SC Pharmaceuticals Inc (SCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 75,655 | 46,814 | 71,243 | 74,450 | 71,819 |
| Marketable Securities | N/A | 29,199 | 47,125 | 1,010 | 33,276 |
| Receivables | 11,721 | 4,489 | N/A | N/A | N/A |
| Inventories | 13,903 | 8,840 | 1,230 | N/A | N/A |
| Other current assets | 1,021 | 1,160 | 1,428 | 24 | 121 |
| TOTAL | $105,849 | $92,938 | $123,308 | $78,275 | $107,826 |
| Non-Current Assets | |||||
| PPE Net | 56 | 58 | 54 | 69 | 93 |
| Other Non-Current Assets | 1,614 | 1,483 | 833 | 693 | 1,129 |
| TOTAL | $1,670 | $1,541 | $887 | $762 | $1,222 |
| Total Assets | $107,519 | $94,479 | $124,195 | $79,037 | $109,048 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 567 | 9,805 | 2,408 |
| Accounts payable and accrued liabilities | 3,883 | 4,001 | 1,518 | 544 | 1,666 |
| Accrued Expenses | 10,702 | 8,901 | 5,289 | 3,995 | 4,787 |
| Other current liabilities | 52 | 56 | 42 | 26 | 0 |
| TOTAL | $14,876 | $13,134 | $7,416 | $14,846 | $9,321 |
| Non-Current Liabilities | |||||
| Long Term Debt | 51,350 | 38,811 | 36,794 | 7,354 | 16,858 |
| Other Non-Current Liabilities | 27,973 | 5,316 | 7,552 | 367 | 699 |
| TOTAL | $79,323 | $44,127 | $44,346 | $7,721 | $17,557 |
| Total Liabilities | $94,199 | $57,261 | $51,762 | $22,567 | $26,878 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,284 | 36,054 | 35,769 | 27,371 | 27,355 |
| Common Shares | 5 | 4 | 3 | 3 | 3 |
| Retained earnings | -366,494 | -281,347 | -226,504 | -189,699 | -161,663 |
| TOTAL | $13,320 | $37,218 | $72,433 | $56,470 | $82,170 |
| Total Liabilities And Equity | $107,519 | $94,479 | $124,195 | $79,037 | $109,048 |